Media
Opinion: Why aren’t doctors telling patients these simple ways to reduce the risk of dementia?
A new clinical trial of the experimental Alzheimer’s drug donanemab has produced promising results, with drugmaker Eli Lilly announcing last week that its phase 3 study showed the medication slowed cognitive decline by an impressive 35% compared with the placebo.
Sleep apnea, lack of deep sleep linked to damage in brain, study says
Uncontrolled sleep apnea — a disorder in which people stop breathing for 10 seconds or more at a time multiple times a night — may harm future brain health, a new study found.
Access to New Alzheimer’s Drugs Might Depend on Where You Live
The rollout of long-awaited Alzheimer’s treatments looks set to start as a case of the haves and the have-nots.
Alzheimer’s first signs may appear in your eyes, study finds
The eyes are more than a window to the soul — they’re also a reflection of a person’s cognitive health.
Mediterranean and MIND diets reduced signs of Alzheimer's in brain tissue, study finds
People who consumed foods from the plant-based Mediterranean and brain-focused MIND diets had fewer of the hallmark signs of Alzheimer’s — sticky beta-amyloid plaques and tau tangles in the brain — when autopsied, a new study found.
Laxative use may be linked to dementia risk, study says
Researchers say they’ve found a possible link between regular laxative use and a person’s risk of dementia, but experts note that the research is very early and should be interpreted with caution.
Dementia risk rises if you live with chronic pain, study says
Chronic pain, such as arthritis, cancer or back pain, lasting for over three months, raises the risk of cognitive decline and dementia, a new study found.
Study presents unexpected — and complicated — findings on link between alcohol and dementia
Keeping alcohol consumption to one or two drinks a day lessened the odds of developing dementia, according to a study of nearly 4 million South Koreans.
New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients
Keeping alcohol consumption to one or two drinks a day lessened the odds of developing dementia, according to a study of nearly 4 million South Koreans.
Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns
The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer’s disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline.